Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

Press releases published on September 29, 2026

Sep. 29, 2026

Nurix Therapeutics Announces Achievement of $7 Million Milestone Under Strategic Collaboration with Pfizer

Indeterminate GlobeNewswire

Sep. 29, 2026

Aquestive Therapeutics Strengthens Board of Directors with Appointment of Richard Daly

Indeterminate GlobeNewswire

Sep. 29, 2026

Iovance Biotherapeutics Raises Full Year 2026 Revenue Guidance to $410 to $420 Million

Indeterminate GlobeNewswire

Sep. 29, 2026

OKYO Pharma Presents and Participates at Upcoming Ophthalmic Scientific Conferences

Indeterminate GlobeNewswire

Sep. 29, 2026

CDT Highlights Sarborg’s Expanding Quantum Computing IP Portfolio and Application to Drug Discovery

Indeterminate GlobeNewswire

Sep. 29, 2026

Immix Biopharma Announces 89% Complete Response Rate at Interim Update Across All NEXICART-2 Patients, with MRD-Negativity Indicating Potential to Reach up to 98% Complete Response Rate, Supporting Potential Best-in-Class Therapy for…

Indeterminate GlobeNewswire

Sep. 29, 2026

Canada’s Coffee Industry Generates $34.7 Billion in Economic Impact

Indeterminate GlobeNewswire

Sep. 29, 2026

Landmark Medicines Advances Proprietary Nasal GLP-1 Platform Towards Human Evaluation

Indeterminate GlobeNewswire

Sep. 29, 2026

4BIO Capital leads €40 Million ($45M) seed financing of Aptadir Therapeutics to advance first-in-class demethylating medicines

Indeterminate GlobeNewswire

Sep. 29, 2026

Caspian Therapeutics Unveils KO-7246 at EASD as a Potential Best-In-Class Menin Inhibitor for Diabetes

Indeterminate GlobeNewswire

Sep. 29, 2026

ANJAC HEALTH & BEAUTY LAUNCHES A DEDICATED OFFERING TO SUPPORT PATIENTS ON GLP-1 TREATMENTS

Indeterminate GlobeNewswire

Sep. 29, 2026

Cyprumed‘s Oral Delivery Technology Advances to Clinical Stage as MSD Initiates Phase I Trial

Indeterminate GlobeNewswire

Sep. 29, 2026

Kither Biotech Initiates Dosing of Patients in Phase 1b / 2a Study of KIT2014 in COPD

Indeterminate GlobeNewswire

Sep. 29, 2026

Breye Therapeutics raises €67.5 million in over-subscribed Series A financing

Indeterminate GlobeNewswire

Sep. 29, 2026

Pentagon Pivots on Havana Syndrome with Re-Branding, Compensation, and a New Study

Indeterminate GlobeNewswire

Sep. 29, 2026

Rapid Nutrition Reports Record Q3 Group Revenue Averaging $1 Million per Month, Up More Than 1,000% on FY2025 Monthly Average

Indeterminate GlobeNewswire

Sep. 29, 2026

AB Science provides an update on its development plan and financial calendar following a sponsor Good Clinical Practice inspection

Indeterminate GlobeNewswire

Sep. 29, 2026

AB Science fait le point sur son plan de developpement et son calendrier financier à la suite d'une inspection promoteur des bonnes pratiques cliniques

Indeterminate GlobeNewswire

Sep. 29, 2026

Carbios and the Fiber-to-Fiber Consortium successfully validate the industrial-scale production of recycled polyester T-shirts made from complex plastic and textile waste.

Indeterminate GlobeNewswire

Sep. 29, 2026

Carbios et le Consortium «fiber-to-fiber» valident la production industrielle de t-shirts en polyester recyclé fabriqués à partir de déchets plastiques et textiles complexes.

Indeterminate GlobeNewswire